BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1487110)

  • 1. The pharmacology of vesamicol: an inhibitor of the vesicular acetylcholine transporter.
    Prior C; Marshall IG; Parsons SM
    Gen Pharmacol; 1992 Nov; 23(6):1017-22. PubMed ID: 1487110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals.
    Parsons RL; Calupca MA; Merriam LA; Prior C
    J Neurophysiol; 1999 Jun; 81(6):2696-700. PubMed ID: 10368389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of uptake and release of newly synthesized acetylcholine in PC12 cells overexpressing the rat vesicular acetylcholine transporter (VAChT).
    Roghani A; Carroll PT
    Brain Res Mol Brain Res; 2002 Apr; 100(1-2):21-30. PubMed ID: 12008018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine transporter--vesamicol receptor pharmacology and structure.
    Parsons SM; Bahr BA; Rogers GA; Clarkson ED; Noremberg K; Hicks BW
    Prog Brain Res; 1993; 98():175-81. PubMed ID: 8248506
    [No Abstract]   [Full Text] [Related]  

  • 5. Piperazine analog of vesamicol: in vitro and in vivo characterization for vesicular acetylcholine transporter.
    Bando K; Naganuma T; Taguchi K; Ginoza Y; Tanaka Y; Koike K; Takatoku K
    Synapse; 2000 Oct; 38(1):27-37. PubMed ID: 10941138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of quantal size by vesamicol (AH5183), an inhibitor of vesicular acetylcholine storage.
    Whitton PS; Marshall IG; Parsons SM
    Brain Res; 1986 Oct; 385(1):189-92. PubMed ID: 3768717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of veratridine on miniature endplate current amplitudes at the rat neuromuscular junction and acetylcholine uptake by Torpedo synaptic vesicles.
    Pemberton KE; Nguyen ML; Prior C; Parsons SM; Marshall IG
    Brain Res; 1995 Feb; 671(2):267-74. PubMed ID: 7743214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical histidine in the vesicular acetylcholine transporter.
    Keller JE; Parsons SM
    Neurochem Int; 2000 Feb; 36(2):113-7. PubMed ID: 10676874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.
    Searl T; Prior C; Marshall IG
    J Physiol; 1991 Dec; 444():99-116. PubMed ID: 1668355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
    Staley JK; Mash DC; Parsons SM; Khare AB; Efange SM
    Eur J Pharmacol; 1997 Nov; 338(2):159-69. PubMed ID: 9455998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of the vesicular acetylcholine transporter domains important for high-affinity transport recognition, binding of vesamicol and targeting to synaptic vesicles.
    Varoqui H; Erickson JD
    J Physiol Paris; 1998 Apr; 92(2):141-4. PubMed ID: 9782458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-hydroxyalkyl derivatives of 3 beta-phenyltropane and 1-methylspiro[1H-indoline-3,4'-piperidine]: vesamicol analogues with affinity for monoamine transporters.
    Efange SM; Kamath AP; Khare AB; Kung MP; Mach RH; Parsons SM
    J Med Chem; 1997 Nov; 40(24):3905-14. PubMed ID: 9397171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of cysteines reveals linkage to acetylcholine and vesamicol binding sites in the vesicular acetylcholine transporter of Torpedo californica.
    Keller JE; Bravo DT; Parsons SM
    J Neurochem; 2000 Apr; 74(4):1739-48. PubMed ID: 10737633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsymmetrical bipiperidyls as inhibitors of vesicular acetylcholine storage.
    Efange SM; Khare A; Parsons SM; Bau R; Metzenthin T
    J Med Chem; 1993 Apr; 36(8):985-9. PubMed ID: 8478910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles.
    Weihe E; Tao-Cheng JH; Schäfer MK; Erickson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3547-52. PubMed ID: 8622973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A kinetic and allosteric model for the acetylcholine transporter-vesamicol receptor in synaptic vesicles.
    Bahr BA; Clarkson ED; Rogers GA; Noremberg K; Parsons SM
    Biochemistry; 1992 Jun; 31(25):5752-62. PubMed ID: 1319200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxylated decahydroquinolines as ligands for the vesicular acetylcholine transporter: synthesis and biological evaluation.
    Efange SM; Khare AB; Mach RH; Parsons SM
    J Med Chem; 1999 Jul; 42(15):2862-9. PubMed ID: 10425095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the rat vesicular acetylcholine transporter.
    Kim MH; Lu M; Rogers G; Parsons S; Hersh LB
    Neurochem Res; 2003 Apr; 28(3-4):473-6. PubMed ID: 12675133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vesamicol and some of its derivatives: questionable ligands for selectively labelling acetylcholine transporters in rat brain.
    Custers FG; Leysen JE; Stoof JC; Herscheid JD
    Eur J Pharmacol; 1997 Nov; 338(2):177-83. PubMed ID: 9456000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routes of acetylcholine leakage from cytosolic and vesicular compartments of rat motor nerve terminals.
    Smith DO
    Neurosci Lett; 1992 Jan; 135(1):5-9. PubMed ID: 1542437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.